World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
42610
World Ranking
11117
National Ranking
1054

Roger W. Blamey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roger W. Blamey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 414 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roger W. Blamey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roger W. Blamey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roger W. Blamey was affiliated with Nottingham City Hospital in the United Kingdom. Their academic career was associated with medical research and clinical practices within this institution.

Though there are no recent papers documented, no frequent co-authors, or publication venues recorded, it is clear that their contributions were primarily tied to their primary affiliation.

There is no detailed information on specific fields of study, subfields, or main topics of work related to Roger W. Blamey in the available data.

Similarly, there are no records of book publications or awards attributed to Roger W. Blamey in the provided source data.

Roger W. Blamey is deceased. The absence of additional bibliographic or scholarly data limits the scope of a detailed academic profile, but their association with Nottingham City Hospital indicates engagement in medical or clinical research activities during their professional tenure.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • The Nottingham Prognostic Index in primary breast cancer.

    Marcus H. Galea;Roger W. Blamey;Christopher E. Elston;Ian O. Ellis

  • A prognostic index in primary breast cancer.

    J L Haybittle;R W Blamey;C W Elston;J Johnson

  • Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction.

    S.K. Al-Ghazal;L. Fallowfield;R.W. Blamey

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

    Emad A. Rakha;Maysa E. El-Sayed;Andrew H. S. Lee;Christopher W. Elston

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

  • Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

    I.O. Ellis;M. Galea;N. Broughton;A. Locker

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • The psychological impact of immediate rather than delayed breast reconstruction.

    SK Al-Ghazal;L Sully;L Fallowfield;RW Blamey

  • Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

    W Jonat;M Kaufmann;W Sauerbrei;R Blamey

  • Investigation of a New Pure Antiestrogen (ICI 182780) in Women with Primary Breast Cancer

    David J DeFriend;Anthony Howell;R I Nicholson;Elizabeth Anderson

  • Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up

    S.E. Pinder;I.O. Ellis;M. Galea;S. O'rouke

  • Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.

    D M Abd El-Rehim;S E Pinder;C E Paish;J A Bell

  • c-erbB-2 oncoprotein expression in primary and advanced breast cancer

    C. Lovekin;I. O. Ellis;A. Locker;J. F. R. Robertson

  • Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases.

    C.J.C. Moffat;S.E. Pinder;A.R. Dixon;C.W. Elston

  • Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

    Julia M. W. Gee;Ian O. Ellis;John F. R. Robertson;Peter Willsher

  • Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

    Emad A. Rakha;Maysa E. El-Sayed;Desmond G. Powe;Andrew R. Green

  • Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.

    Anthony Howell;D J DeFriend;J F Robertson;R W Blamey

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
C.W. Elston
C.W. Elston University of Nottingham
Robert Ian Nicholson
Robert Ian Nicholson Cardiff University
John F.R. Robertson
John F.R. Robertson University of Nottingham
Sarah E Pinder
Sarah E Pinder King's College London
Andrew Evans
Andrew Evans University of Dundee
Anthony Howell
Anthony Howell University of Manchester
Julia Margaret Wendy Gee
Julia Margaret Wendy Gee Cardiff University
Robert L. Sutherland
Robert L. Sutherland Garvan Institute of Medical Research
Emad A. Rakha
Emad A. Rakha University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but looking for flexible study options, several online degrees can help jumpstart your journey. For those interested in hands-on patient care, fast track lpn programs offer a quicker route to becoming a licensed practical nurse, combining convenience with strong job demand.

If you already have nursing experience and are eager to specialize further, psych nurse practitioner programs are available online so you can advance your career in mental health without relocating or pausing your job.

Management roles in healthcare are also becoming increasingly popular. Consider pursuing an online healthcare administration degree to gain vital business and organizational skills. If you plan to ascend even further, the masters in healthcare administration cost can be affordable when you choose the right program.

Each of these online pathways offers unique benefits, allowing you to align your studies with your personal and career goals in the evolving healthcare landscape.

Best Scientists Citing Roger W. Blamey

Recently Published Articles